Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Promore Pharma

Less than 1K followers
All
Press releases
ShowingAll content types

Regulatory press release14.01.2025, 17.38

PMD Device Solutions' Bankruptcy Application Granted

Promore Pharma
Regulatory press release22.12.2024, 16.03

PMD Device Solutions AB (publ) has Filed for Bankruptcy

Promore Pharma
Regulatory press release29.11.2024, 08.00

Q3 Interim report July - September 2024

Promore Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release26.11.2024, 08.30

PMD Device Solutions Completes Sale of Coala Life Monitor to Inventor Magnus Sörlander

Promore Pharma
Regulatory press release20.11.2024, 13.12

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

Promore Pharma
Regulatory press release05.11.2024, 16.37

PMDS announces last day of trading in BTA

Promore Pharma
Regulatory press release29.10.2024, 14.13

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release29.10.2024, 14.10

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release14.10.2024, 07.00

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Regulatory press release11.10.2024, 09.22

PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes

Promore Pharma
Regulatory press release07.10.2024, 17.01

PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion

Promore Pharma
Regulatory press release26.09.2024, 13.34

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Press release17.09.2024, 13.39

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

Promore Pharma
Regulatory press release12.09.2024, 16.55

PMDS carries out a directed issue of shares to underwriter in the completed rights issue

Promore Pharma
Press release11.09.2024, 08.04

PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability

Promore Pharma
Press release05.09.2024, 19.18

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

Promore Pharma
Regulatory press release04.09.2024, 21.44

PMDS announces outcome of rights issue

Promore Pharma
Press release27.08.2024, 10.34

Redeye: PMD Solutions - PMD is approaching a cash-positive run rate before 2025

Promore Pharma
Regulatory press release22.08.2024, 08.00

Q2 Interim report April-June 2024

Promore Pharma
Regulatory press release16.08.2024, 23.15

PMDS publishes information memorandum in connection with the forthcoming rights issue

Promore Pharma